650 related articles for article (PubMed ID: 8970342)
1. An inhaled glucocorticoid does not prevent tolerance to the bronchoprotective effect of a long-acting inhaled beta 2-agonist.
Yates DH; Kharitonov SA; Barnes PJ
Am J Respir Crit Care Med; 1996 Dec; 154(6 Pt 1):1603-7. PubMed ID: 8970342
[TBL] [Abstract][Full Text] [Related]
2. Inhaled corticosteroids do not prevent the development of tolerance to the bronchoprotective effect of salmeterol.
Kalra S; Swystun VA; Bhagat R; Cockcroft DW
Chest; 1996 Apr; 109(4):953-6. PubMed ID: 8635376
[TBL] [Abstract][Full Text] [Related]
3. Effect of regular salmeterol treatment on albuterol-induced bronchoprotection in mild asthma.
Yates DH; Worsdell M; Barnes PJ
Am J Respir Crit Care Med; 1997 Sep; 156(3 Pt 1):988-91. PubMed ID: 9310023
[TBL] [Abstract][Full Text] [Related]
4. Long-term effects of a long-acting beta 2-adrenoceptor agonist, salmeterol, on airway hyperresponsiveness in patients with mild asthma.
Cheung D; Timmers MC; Zwinderman AH; Bel EH; Dijkman JH; Sterk PJ
N Engl J Med; 1992 Oct; 327(17):1198-203. PubMed ID: 1357550
[TBL] [Abstract][Full Text] [Related]
5. Rebound airway obstruction and responsiveness after cessation of terbutaline: effects of budesonide.
de Jong JW; van der Mark TW; Koëter GH; Postma DS
Am J Respir Crit Care Med; 1996 Jan; 153(1):70-5. PubMed ID: 8542165
[TBL] [Abstract][Full Text] [Related]
6. Interaction of inhaled beta 2 agonist and inhaled corticosteroid on airway responsiveness to allergen and methacholine.
Cockcroft DW; Swystun VA; Bhagat R
Am J Respir Crit Care Med; 1995 Nov; 152(5 Pt 1):1485-9. PubMed ID: 7582281
[TBL] [Abstract][Full Text] [Related]
7. Effect of long-term salmeterol therapy compared with as-needed albuterol use on airway hyperresponsiveness.
Rosenthal RR; Busse WW; Kemp JP; Baker JW; Kalberg C; Emmett A; Rickard KA
Chest; 1999 Sep; 116(3):595-602. PubMed ID: 10492259
[TBL] [Abstract][Full Text] [Related]
8. Decreased bronchodilating effect of salbutamol in relieving methacholine induced moderate to severe bronchoconstriction during high dose treatment with long acting beta2 agonists.
van der Woude HJ; Winter TH; Aalbers R
Thorax; 2001 Jul; 56(7):529-35. PubMed ID: 11413351
[TBL] [Abstract][Full Text] [Related]
9. Effects of theophylline on tolerance to the bronchoprotective actions of salmeterol in asthmatics in vivo.
Cheung D; Wever AM; de GOEIJ JA; de GRAAFF CS; Steen H; Sterk PJ
Am J Respir Crit Care Med; 1998 Sep; 158(3):792-6. PubMed ID: 9731006
[TBL] [Abstract][Full Text] [Related]
10. Salbutamol tolerance to bronchoprotection: course of onset.
Stewart SL; Martin AL; Davis BE; Cockcroft DW
Ann Allergy Asthma Immunol; 2012 Dec; 109(6):454-7. PubMed ID: 23176887
[TBL] [Abstract][Full Text] [Related]
11. A high dose of albuterol does not overcome bronchoprotective subsensitivity in asthmatic subjects receiving regular salmeterol or formoterol.
Lipworth BJ; Aziz I
J Allergy Clin Immunol; 1999 Jan; 103(1 Pt 1):88-92. PubMed ID: 9893190
[TBL] [Abstract][Full Text] [Related]
12. The effect of reducing the fine-particle mass of salmeterol from metered-dose inhalers on bronchodilatation and bronchoprotection against methacholine challenge: a randomized, placebo-controlled, double-blind, crossover study.
Langley SJ; Allen D; McDonnell B; Wheeler N; Sharma RK; Sykes A; Woodcock A
Clin Ther; 2005 Jul; 27(7):1004-12. PubMed ID: 16154479
[TBL] [Abstract][Full Text] [Related]
13. Comparison of salmeterol and albuterol-induced bronchoprotection against adenosine monophosphate and histamine in mild asthma.
Taylor DA; Jensen MW; Aikman SL; Harris JG; Barnes PJ; O'Connor BJ
Am J Respir Crit Care Med; 1997 Dec; 156(6):1731-7. PubMed ID: 9412548
[TBL] [Abstract][Full Text] [Related]
14. Budesonide/formoterol in a single inhaler rapidly relieves methacholine-induced moderate-to-severe bronchoconstriction.
van der Woude HJ; Boorsma M; Bergqvist PB; Winter TH; Aalbers R
Pulm Pharmacol Ther; 2004; 17(2):89-95. PubMed ID: 15123230
[TBL] [Abstract][Full Text] [Related]
15. Tolerance to the bronchoprotective effect of salmeterol 12 hours after starting twice daily treatment.
Drotar DE; Davis EE; Cockcroft DW
Ann Allergy Asthma Immunol; 1998 Jan; 80(1):31-4. PubMed ID: 9475563
[TBL] [Abstract][Full Text] [Related]
16. The effect of regular inhaled albuterol on exercise-induced bronchoconstriction.
Inman MD; O'Byrne PM
Am J Respir Crit Care Med; 1996 Jan; 153(1):65-9. PubMed ID: 8542164
[TBL] [Abstract][Full Text] [Related]
17. Greater effect of inhaled budesonide on adenosine 5'-monophosphate-induced than on sodium-metabisulfite-induced bronchoconstriction in asthma.
O'Connor BJ; Ridge SM; Barnes PJ; Fuller RW
Am Rev Respir Dis; 1992 Sep; 146(3):560-4. PubMed ID: 1519828
[TBL] [Abstract][Full Text] [Related]
18. Effect of an inhaled glucocorticosteroid on mast cell and smooth muscle beta 2 adrenergic tolerance in mild asthma.
Yates DH; Worsdell M; Barnes PJ
Thorax; 1998 Feb; 53(2):110-3. PubMed ID: 9624295
[TBL] [Abstract][Full Text] [Related]
19. Effect of short- and long-acting inhaled beta2-agonists on exhaled nitric oxide in asthmatic patients.
Yates DH; Kharitonov SA; Barnes PJ
Eur Respir J; 1997 Jul; 10(7):1483-8. PubMed ID: 9230234
[TBL] [Abstract][Full Text] [Related]
20. Tolerance to bronchodilation during treatment with long-acting beta-agonists, a randomised controlled trial.
Haney S; Hancox RJ
Respir Res; 2005 Sep; 6(1):107. PubMed ID: 16168062
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
